FDA Inspection 1181604 — Cooperation Pharmaceutique Francaise

Cooperation Pharmaceutique Francaise — FEI 3002420713

The FDA completed an inspection of Cooperation Pharmaceutique Francaise on November 27, 2020 in Melun. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 27, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melun (France)

Additional Details

Mutual Recognition Agreement (MRA)